Based on the exploration of literature as well as the current situation regarding the treatment of breast cancer, the central objective of the current study was to investigate whether miR-98 could suppress the cell proliferation, invasion and migration of breast cancer via binding to HMGA2 in a bid to discover a potential biomarker for improved breast cancer treatment. The gene discussed is HMGA2; the disease is breast carcinoma.